Patient orders · Approved
Approved by your clinician. Now — and only now — the cost.
Reference MEC-4821. Reviewed and approved by your Medical Director on 13 June 2026.
Thyroid replacement · 90-day continuation
Your interval TSH was within target. Continuation approved at the current dose with a repeat draw at week ten, then a review of trend rather than a single value.
Thyroid replacement
Daily oral capsule · current dose continued
90-day supply
$96Interval monitoring
TSH and free T4 at week 10, drawn in clinic
One draw
$74Nurse review
Fifteen-minute call to confirm tolerance and next steps
Included
Included
- 01
Care team handoff
A member of our care team calls you to confirm the plan, answer questions and arrange payment. Nothing is charged automatically.
- 02
Invoice to your account
You receive an itemized invoice through your patient portal, payable by card, bank transfer, HSA or FSA.
- 03
Documentation for reimbursement
We provide the coding and documentation needed for insurance or HSA/FSA reimbursement where it applies.
Approved. Awaiting payment arrangement.
Request received
Your request is logged to your chart. Nothing is dispensed and nothing is charged at this stage.
Clinical review
A licensed clinician reviews your request against your history, current medications and most recent results.
Clarification, if needed
We may ask a short follow-up question, request an interval lab, or schedule a brief call before deciding.
Clinical decision
Your clinician approves, adjusts, or declines the request — and explains the reasoning either way.
Approved plan released
Only once approved do you see the prescribed protocol, quantities, monitoring schedule and cost.
Current stagePayment arranged
Our care team arranges payment with you directly. Payment is never taken before a clinician has approved your plan.
Dispensing & delivery
The pharmacy prepares your therapy for clinic pickup or temperature-controlled delivery.
Monitoring & follow-up
Your nurse confirms administration, monitoring intervals and the date of your next review.
